Mark is the Managing Director of Good Health Capital, a healthcare PEVC firm with offices in New York and Shanghai, and Chairman of World Biotech Capital LLC, a cross-border venture capital, M&A, licensing, and IPO advisory firm. Originally from mainland China and educated in the US, Mark is a veteran Chinese biotech investor with over two decades of experience in the field of biotechnology as an entrepreneur, educator, advisor, and investor. He served as the biotech director at Rutgers Business School and as a lecturer at Rockefeller University. Mark has worked at investment banks, including Morgan Stanley Dean Witter and UBS PaineWebber. He is the author of "The Essential Biotech Investment Handbook,"which is published in both English and Chinese. Mark has co-founded two tech startups that have achieved successful exits and currently sits on the boards of two US biotech companies. He holds degrees from NYU Stern School of Business and the Harvard T.H. Chan School of Public Health.